Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L M Pozzi

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)|September 15, 1991
Human recombinant migration inhibitory factor activates human macrophages to kill Leishmania donovaniW Y Weiser, L M Pozzi, J R David
Proceedings of the National Academy of Sciences of the United States of America|September 1, 1992
Recombinant human migration inhibitory factor has adjuvant activityW Y Weiser, L M Pozzi, R G Titus, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 7, 1997
Recombinant human migration inhibitory factor has adjuvant activityW Y Weiser, L M Pozzi, R G Titus, et al.
Antimicrobial Agents and Chemotherapy|January 1, 1993
A point mutation in the human cytomegalovirus DNA polymerase gene confers resistance to ganciclovir and phosphonylmethoxyalkyl derivativesV Sullivan, K K Biron, C Talarico, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Journal of Immunology (Baltimore, Md. : 1950)|September 15, 1991
Human recombinant migration inhibitory factor activates human macrophages to kill Leishmania donovaniW Y Weiser, L M Pozzi, J R David
Proceedings of the National Academy of Sciences of the United States of America|September 1, 1992
Recombinant human migration inhibitory factor has adjuvant activityW Y Weiser, L M Pozzi, R G Titus, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 7, 1997
Recombinant human migration inhibitory factor has adjuvant activityW Y Weiser, L M Pozzi, R G Titus, et al.
Antimicrobial Agents and Chemotherapy|January 1, 1993
A point mutation in the human cytomegalovirus DNA polymerase gene confers resistance to ganciclovir and phosphonylmethoxyalkyl derivativesV Sullivan, K K Biron, C Talarico, et al.
Pageof 1